Use this form to request a free consultation with a qualified attorney near you.
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
Lamisil is a tablet medication for the treatment of onychomycosis, or nail fungus. The FDA issued a public health advisory warning physicians of the link between Lamisil and hepatic adverse events. The Lamisil risks include liver failure that can lead to death or liver transplant. Manufacturer Novartis Pharmaceuticals revised the labeling for Lamisil in the Warnings, Precautions, and Adverse Reactions sections.
The FDA received 16 reports of liver failure cases in Lamisil patients as of April 2001. In addition, prescribing errors have occurred instead of prescribing Lamisil patients have received Lamictal, an anti-epileptic. Please contact us for more information on Lamisil.
More Lamisil Resources
MedLine Plus Drug Information - Guide to prescription and over-the-counter medications provided by the United States Pharmacopeia.
Lamisil.com - Lamisil tablets official site for fungal nail infections.